Sponsors (23)
This resolution increases recognition and targeted outreach for fibroids—potentially improving care and reducing disparities—while risking more interventions, added federal costs, and only time-limited attention if not sustained.
Women with fibroids may receive greater recognition and prioritization for research, screening, and treatment programs, increasing resources and attention to the condition.
Black and Hispanic women may receive more targeted outreach and programs because the resolution calls out their higher incidence, helping reduce racial disparities in diagnosis and care.
Symptomatic women and their families could face fewer diagnostic delays and improved quality of life, reducing work disruption and associated economic burdens through increased awareness.
Women with fibroids may experience increased rates of screening and interventions (including hysterectomies), which could raise surgical risks, complications, and downstream health costs.
Taxpayers could face higher federal spending if the increased attention leads to new programs or funding to address fibroids and their costs.
Women may get concentrated outreach during the designated awareness month (July) but receive less sustained attention the rest of the year if follow-up efforts are not maintained.
Based on analysis of 2 sections of legislative text.
Formally records congressional findings that uterine fibroids are a widespread, costly public health issue with substantial clinical burden and racial disparities, and notes July awareness efforts.
Official title: Supporting the designation of July as Uterine Fibroids Awareness Month.
Introduced July 14, 2025 by David Scott · Last progress July 14, 2025
Recognizes uterine fibroids as a significant public health issue by listing findings on their prevalence, symptoms, disparities, economic costs, common treatments (including frequent hysterectomy), and existing public awareness efforts held in July. The resolution compiles evidence about how fibroids harm quality of life, work productivity, and reproductive outcomes — and highlights higher incidence among Black and Hispanic women.